It is with great pleasure that A.forall can inform all of you that, after our ANDA for Magnesium Sulfate in Water for Injection was approved last year, the product has now been launched in the U.S. Market!
The product is being marketed through our partner Avenacy, a leading specialty pharmaceutical company. “We’re excited to work with Avenacy to introduce Magnesium Sulfate in Water for Injection to the market,” says Erik Lazarich, President of A.forall’s U.S. Operations, “Delivering this ready-to-use product to hospitals nationwide is a key step in improving patient care and advancing our mission of making affordable medicines available to all.”
Magnesium Sulfate Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia. When used judiciously, it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant.
Check out the full press release here!
